Form 4: ResMed Director Exercises Stock Options, Disposes of Shares

ResMed director Peter C. Farrell exercised stock options and disposed of shares on November 25, 2024.

Summary

• Peter C. Farrell, a director at ResMed Inc., executed a transaction involving the company's stock on November 25, 2024.
• Mr. Farrell acquired 1,468 shares of ResMed common stock through the exercise of stock options at a price of $249.56 per share.
• He also disposed of 83,218 shares of ResMed common stock.
• Following these transactions, Mr. Farrell directly owns 1,468 shares of ResMed common stock.

Sentiment

Score: 5

Explanation: The document is a routine filing of insider transactions, which is neither positive nor negative for the company's overall outlook.

Industry Context

This is a routine filing related to insider transactions and is common for publicly traded companies. It does not indicate any specific trend in the medical device industry.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is consistent with typical insider trading activity.
• The exercise of stock options and subsequent disposal of shares is a common occurrence for directors and officers of public companies.

Stakeholder Impact

• The transaction may have a minor impact on the stock price due to the disposal of a large number of shares, but it is not expected to be significant.

Key Dates

Keywords

ResMed, Stock Options, Director Transaction, Form 4, Beneficial Ownership, Equity Securities